ClinGen Actionability GCH1
This is a genotype with recommended actions if clinically confirmed. In brief:
- Be aware that penetrance varies widely, including between genders.
- Have an exam by a movement disorder specialist at least several times a year.
- If diagnosed, consider levodopa administration.
- Evaluate relatives at risk in order to identify as early as possible those who would benefit from initiation of treatment.
The full ClinGen Actionability report about GCH1-deficient dopa-responsive dystonia (DRD) can be found here.
Genetic counseling may be available to you through your health-care network. Additional information is available via our Find A Genetic Counselor webpage, located here.